Cover
Vol. 8 No. 1 (2018)

Published: June 30, 2018

Pages: 10-21

Research Article

Although Late; but the First, an Iraqi Success in Human Em-bryo Cryopreservation Using Vitrification and the Factors Af-fecting the Pregnancy Rate: Cross-Sectional Study

Abstract

Background: it is important to study a history of the science to appreciate the past as a motive for hard work in the present for better future. In the other hand, the factors affecting pregnancy rate of frozen embryos are yet to be clarified at different embryonic developmental stages. Objectives: to record a brief history of embryo cryopreservation in Iraq and to study many clinical and embryological factors that might affect the pregnancy rate. Subjects, materials and Method: a cross-sectional study of many clinical and em-bryological variable, where120 frozen-thawed embryo transfer cycles enrolled in the study at the period from January 2017 till July 2018. The variables were sta-tistically analyzed first by one factor analysis comparing between pregnant and non-pregnant cases; then by multivariate logistic regression analysis to illustrate main factors without a possible confounder effect. Results: In one factor analysis, the following variables showed a significantly high effect on pregnancy rate (P value <0.001) which are women’s age, women’s weight, number of retrieved oocytes, mature oocytes and good quality embryos, developmental stage, E2 level, and endometrial thickness. While in multivariate logistic regression analysis the women’s weight, the number of retrieved oocytes and good quality embryos were the main factors. Conclusions: it is judiciously to consider these factors while managing infertile couples with embryo cryopreservation programs especially the modifiable fac-tors.

References

  1. Nagy Z, Chang C and Vajta G: The hu- man embryo: Vitrification. In Textbokk of Assisted Reproductive Techniques. Eds. Gardner D., Weissman A., Howles C. and Shohan Z. 2012, 4th Ed., Vol 1, Taylor & Francis Group.
  2. Zdravka V, Mauri O, Sinikka N, Juha S and Hannu M: Factors affecting the outcome of frozen–thawed embryo trans- fer. Hum Reprod, 2013; 28, 9, 2425– 2431.
  3. Richter KS, Graham JR and Tucker MJ: Scrying the future: The ongoing transfor- mation of reproductive medicine through vitrification. In Vitrification in Assisted Reproduction. Eds. Tucker MJ and Lieb- ermann J, 2016; 2nd Ed., Taylor & Fran- cis Group.
  4. Nagy Z, Chang C and Vajta G: The hu- man embryo: Vitrification. In Textbokk of Assisted Reproductive Techniques. Eds. Gardner D., Weissman A., Howles C. and Shohan Z. 2018, 5th Ed., Vol 1, Taylor & Francis Group.
  5. Lin D, Ran J, Chen C, Luo Z, Quan S, Ye B, Yu A, Kang Yand Lin Y: Frozen tow day 3 embryos and subsequently pro- duced blastocysts by vitrification: advan- tages for IVF/ICSI patients at high risk of ovarian hyperstimulation syndrome. Int J Clin Med, 2016; 9 (3), 6986-6999.
  6. Cheung A, Sierra S, Carranza-Mamane B, Case A, Dwyer C, Graham J, Havelock J, Healey S, Hemmings R, Liu K, Mor- tan T, Murdock W, Smithson D, Vause T, Wong B and Gysler M: The Prevention of Ovarian Hyperstimulation Syndrome. J Obstet Gynaecol Can, 2014; 36(11), 1024–1033.
  7. ESHRE ART fact sheet, Press Informa- tion, Updated 18 February 2018.
  8. Mills M, Rindfuss R, McDonald P and te Velde E: Why do people postpone par- enthood? Reasons and social policy in- centives. Hum Reprod Update, 2011; 17, 848-860.
  9. Schmidt L, Sobotka T, Bentzen J and Andersen N: Demographic and medical consequences of the postponement of parenthood. Hum Reprod Update, 2011; 18, 29-43.
  10. Homan G, Davies M and Norman R: The impact of lifestyle factors on repro- ductive performance in the general pop- ulation and those undergoing infertility treatment: a review. Hum Reprod Update, 2007; 13, 209-223.
  11. Macaldowie A, Wang YA, Chambers GM and Sullivan EA: Assisted reproduc- tive technology in Australia and New- Zealand 2010. Assist reprod tech series no.16, 2012; Canberra, AIHW.
  12. Hourvitz A, Machtinger R, Maman E, Baum M, Dor J and Levron, J: Assisted Reproduction in women over 40 years of age: How old is too old?. RBM Online, 2009; 19, 599-603.
  13. ESHRE Capri Workshop Group: Fer- tility and aging. Hum Reprod Update, 2005; 11, 261-276.
  14. Grøndahl ML, Christiansen SL, Kes- model US, Agerholm IE, Lemmen JG, Lundstrøm P, Bogstad J, Raaschou-Jensen M and Ladelund S: Effect of women’s age on embryo morphology, cleavage rate and competence—A multicenter cohort study. PloS one, 2017; 19;12(4):e0172456.
  15. Chen R, Chen S, Liu M, He H, Xu H, Liu H, Du H, Wang W, Xia X and Liu J: Pregnancy outcomes of PCOS over- weight/obese patients after controlled ovarian stimulation with the GnRH an- tagonist protocol and frozen embryo transfer. Reprod Bio and Endoc, 2018;
  16. Rahim AI: Impact of Women’s Body Mass Index (BMI) on the Outcomes of In- tra-Cytoplasmic Sperms Injection (ICSI). Iraqi Journal Of Embryos and Infertility Researches Vol.(8) Issue-1 (2018) QMJ, 2016; 12, 21, 93-99.
  17. Tremellen K, Pearce K and Zan- der-Fox D: Increased miscarriage of eu- ploid pregnancies in obese women un- dergoing cryopreserved embryo transfer. RBM Online, 2017; 34, 90-97.
  18. Metwally M, Cutting R and Tipton A: Effect of increased body mass index on oocyte and embryo quality in IVF patients. RBM Online 2007; 15, 532- 538.
  19. Provost MP, Acharya KS, Acharya CR, Yeh JS, Steward RG, Eaton JL, Goldfarb JM and Muasher SJ: Pregnancy outcomes decline with increasing recipient body mass index: an analysis of22,317 fresh donor/recipient cycles from the 2008- 2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry. Fertil Steril, 2016; 105, 364–368.
  20. Tremellen K, Syedi N, Tan S and Pearce K: Metabolic endotoxaemia – a potential novel link between ovarian in- flammation and impaired progesterone production. Gynecol Endocrinol, 2015; 31, 309–312.
  21. Rochester D, Jain A, Polotsky AJ, Polotsky H, Gibbs K, Isaac B, Zeitlian G, Hickmon C, Feng S and Santoro N: Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril, 2009; 92, 1410–1415.
  22. Rhee JS, Saben JL, Mayer AL, Schulte MB, Asghar Z, Stephens C, Chi MM and Moley KH: Diet-induced obesity impairs endometrial stromal cell decidualization: a potential role for impaired autophagy. Hum Reprod, 2016; 31, 1315–1326.
  23. Metwally M, Preece R, Thomas J, Led- ger W and Li TC: A proteomic analysis of the endometrium in obese and overweight women with recurrent miscarriage: pre- liminary evidence for an endometrial de- fect. Reprod Biol Endocrinol, 2014; 12, 75.
  24. Martino J, Sebert S, Segura MT, García-Valdés L, Florido J, Padilla MC, Marcos A, Rueda R, McArdle HJ, Budge H, Symonds ME and Campoy C: Iraqi Journal Of Embryos and Infertility Researches Vol.(8) Issue-1 (2018) Maternal body weight and gestational di- abetes differentially influence placental and pregnancy outcomes. J Clin Endocri- nol Metab, 2016; 101, 59–68.
  25. Bellver J, De Los Santos MJ, Alamá P, Castelló D, Privitera L, Galliano D, La- barta E, Vidal C, Pellicer A and Domín- guez F: Day-3 embryo metabolomics in the spent culture media is altered in obese women undergoing in vitro fertilization. Fertil Steril, 2015; 103, 1407–1415.
  26. Tulic L, Vidakovic S, Tulic I, Curcic M, Stojnic J and Jeremic K: Oxidative Stress Markers in GnRH Agonist and An- tagonist Protocols in IVF. J of Med Bio- chem, 2017; 36, 1-8.
  27. Singh N, Naha M, Malhotra N, Lata K, Vanamail P and Tiwari A: Comparison of gonadotropin-releasing hormone ago- nist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literature. J of hum reprod scien, 2014; 7(1):52.
  28. Al-Inany HG, Youssef MA, Aboul- ghar M, Broekmans F, Sterrenburg M, Smit J, et al. Gonadotrophin-releasing hormone antagonists for assisted re- productive technology. Cochrane Da- tabase Syst Rev. 2011; 5: CD001750. doi: 10.1002/14651858. CD001750.pub 3.
  29. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K and Griesing- er G: Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update, 2006; 12, 651–671.
  30. Shi W, Zhang S, Zhao W, Xia X and Wan M: Factors related to clinical preg- nancy after vitrified–warmed embryo transfer: a retrospective and multivari- ate logistic regression analysis of 2313 transfer cycles. Hum Reprod, 2013; 28, 7, 1768–1775.
  31. Lin YP, Cassidenti DL, Chacon RR, Soubra SS, Rosen GF and Yee B: Suc- cessful implantation of frozen sibling embryos is influenced by the outcome of the cycle from which they were derived. Fertil Steril 1995; 63, 262–267.
  32. Toner JP, Veeck L, Acosta AA and Muasher SJ: Predictive value of pregnan- cy during original in vitro fertilization cycle on implantation and pregnancy in subsequent cryothaw cycles. Fertil Steril, 1991; 56, 505–508.
  33. Urman B, Balaban B and Yakin K: Impact of fresh-cycle variables on the implantation potential of cryopre- served-thawed human embryos. Fertil Steril, 2007; 87, 310–315.
  34. El-Toukhy T, Khalaf Y, Al-Darazi K, Andritsos V, Taylor A and Braude P: Ef- fect of blastomere loss on the outcome of frozen embryo replacement cycles. Fertil Steril, 2003; 79, 1106–1111.
  35. El-Toukhy T, Khalaf Y, Al-Darazi K, O’Mahony F, Wharf E, Taylor A and Braude P: Cryo-thawed embryos obtained from conception cycles have double the implantation and pregnancy potential of those from unsuccessful cycles. Hum Re- prod 2003; 18, 1313–1318.
  36. Darkopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H and Plyzos NP: Conventional ovarian stim- ulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?. Hum Reprod, 2016; 31, 370- 376.
  37. Vanderzwalmen P, Zech NH, Ectors F, Stecher A, Lejeune B, Vanderzwal- men S, Wirleitner B: Blastocyst transfer after aseptic vitrification of zygotes: an approach to overcome an impaired uter- ine environment. RBM Online, 2012; 25, 591-599.
  38. Arslan M, Bocca S, Ozturk E, Duran E, Stadtmauer L and Oehninger S: Cu- mulative exposure to high estradiol lev- els during follicular phase of IVF cycles negatively affects implantation. J Assist Reprod Genet, 2007; 24, 111–117.
  39. Basir G, Wai-sum O, Ng E and Ho P: Morphometric analysis of periimplanta- tion endometrium in patients having ex- cessively high estradiol concentrations after ovarian stimulation. Hum Reprod, 2001; 16, 435–440.
  40. Yu Ng EH, Yeung WS, Yee Lan Lau E, So WW and Ho PC: High serum oes- tradiol concentrations in fresh IVF cycles do not impair implantation and pregnan- cy rates in subsequent frozen-thawed em- bryo transfer cycles. Hum Reprod. 2000; 15(2), 250-255.
  41. Haouzi D, Assou S, Mahmoud K, Ton- deur S, Rème T, Hedon B, De Vos J and Hamamah S: Gene expression profile of human endometrial receptivity: compar- ison between natural and stimulated cy- cles for the same patients. Hum Reprod, 2009; 24, 1436–1445.
  42. Zhou F, Lin XN, Tong XM, Li C, Liu L, Jin XY, Zhu HY and Zhang SY: A fro- zen–thawed embryo transfer program im- proves the embryo utilization rate. China Med J, 2009; 122, 1974–1978.
  43. Rahim AI, Devroey P, Diedrich K and Al-Hasani S: Cancellation of fresh embryo transfer: A future perspective. MEFS J, 2010; 15, 240-242.
  44. El-Toukhy T, Coomarasamy A, Khairy M, Sunkara K, Seed P, Khalaf Y and Braude P: The relationship between en- dometrial thickness and outcome of med- icated frozen embryo replacement cycles. Fertil Steril, 2008; 89, 832–839.
  45. Schnorr JA: Assisted Reproductive Technologies. In: Reproductive Endo- crinology & Infertility – Handbook for Clinician. Eds. Lebovic DI, Gordon JD and Taylor RN, 2005; 1st Ed., ScrubHill Press, Inc. USA. Iraqi Journal Of Embryos and Infertility Researches Vol.(8) Issue -1(2018)